Cargando…

Comparison of the Association of Excess Weight on Health Related Quality of Life of Women with Polycystic Ovary Syndrome: An Age- and BMI-Matched Case Control Study

BACKGROUND: It is assumed that obesity adversely affects the health related quality of life (HRQOL) of women with polycystic ovary syndrome (PCOS), not only due to the excess weight, but also due to several other obesity induced metabolic and reproductive consequences. We aimed to compare the effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shishehgar, Farnaz, Ramezani Tehrani, Fahimeh, Mirmiran, Parvin, Hajian, Sepideh, Baghestani, Ahmad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063389/ https://www.ncbi.nlm.nih.gov/pubmed/27736861 http://dx.doi.org/10.1371/journal.pone.0162911

Ejemplares similares

Comparison of Dietary Intake between Polycystic Ovary Syndrome Women and Controls
por: Shishehgar, Farnaz, et al.
Publicado: (2016)

Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
por: Shishehgar, Farnaz, et al.
Publicado: (2019)

The effects of weight loss on health-related quality of life in obese women with PCOS and controls
por: Shishehgar, Farnaz, et al.
Publicado: (2023)

Low birth weight may increase body fat mass in adult women with polycystic ovarian syndrome
por: Minooee, Sonia, et al.
Publicado: (2016)

Polycystic Ovary Syndrome: An Apparently Simple yet Challenging Diagnosis
por: Ramezani Tehrani, Fahimeh
Publicado: (2015)

Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2019)

Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review
por: Saei Ghare Naz, Marzieh, et al.
Publicado: (2020)

Polycystic Ovary Syndrome in adolescents: a qualitative study
por: Saei Ghare Naz, Marzieh, et al.
Publicado: (2019)

The Polycystic Ovary Syndrome Health-Related Quality-of-Life Questionnaire: Confirmatory Factor Analysis
por: Nasiri-Amiri, Fatemeh, et al.
Publicado: (2018)

Visfatin and Resistin Serum Levels in Normal-Weight and Obese Women With Polycystic Ovary Syndrome
por: Farshchian, Fatemeh, et al.
Publicado: (2014)

The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study
por: Tehrani, Fahimeh Ramezani, et al.
Publicado: (2011)

Quality of Life and Emotional States of Depression, Anxiety and Stress in Adolescents with Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Saei Ghare Naz, Marzieh, et al.
Publicado: (2020)

The Experience of Women Affected by Polycystic Ovary Syndrome: A Qualitative Study From Iran
por: Nasiri Amiri, Fatemeh, et al.
Publicado: (2014)

Female Gender Scheme is Disturbed by Polycystic Ovary Syndrome: A Qualitative Study From Iran
por: Nasiri Amiri, Fatemeh, et al.
Publicado: (2014)

Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome
por: Hatami, Hossein, et al.
Publicado: (2017)

Contractions in the Isolated Uterus of a Rat Model of Polycystic Ovary Syndrome Compared to Controls in Adulthood
por: Sajadi, Maryam, et al.
Publicado: (2018)

Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials
por: Amini, Leila, et al.
Publicado: (2015)

Turning the Threat of SARS-CoV-2 Crisis into an Opportunity for a Better Lifestyle in Adolescents with Polycystic Ovary Syndrome
por: Saei Ghare Naz, Marzieh, et al.
Publicado: (2021)

A Meta-Analysis of Observational Studies on Prolactin Levels in Women with Polycystic Ovary Syndrome
por: Saei Ghare Naz, Marzieh, et al.
Publicado: (2022)

Inflammatory Responses of Women with Polycystic Ovary Syndrome in Vitro Differ from Healthy Women
por: Rezayat, Fatemeh, et al.
Publicado: (2023)

Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
por: Amiri, Mina, et al.
Publicado: (2020)

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study
por: Tehrani, Fahimeh Ramezani, et al.
Publicado: (2011)

Do dietary intakes influence the rate of decline in anti-Mullerian hormone among eumenorrheic women? A population-based prospective investigation
por: Moslehi, Nazanin, et al.
Publicado: (2019)

Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression
por: Amiri, Mina, et al.
Publicado: (2020)

Possible cognition changes in women with polycystic ovary syndrome: a narrative review
por: Naz, Marzieh Saei Ghare, et al.
Publicado: (2023)

The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2014)

Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: A systematic review and meta-analysis
por: Amiri, Mina, et al.
Publicado: (2022)

Prenatal kisspeptin antagonist exposure prevents polycystic ovary syndrome development in prenatally-androgenized rats in adulthood: An experimental study
por: Sadeghian Bakhi, Elahe, et al.
Publicado: (2023)

The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta-analysis
por: Naz, Marzieh Saei Ghare, et al.
Publicado: (2019)

The Time of Prenatal Androgen Exposure Affects Development of Polycystic Ovary Syndrome-Like Phenotype in Adulthood in Female Rats
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2014)

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study
por: Yuan, Chun, et al.
Publicado: (2016)

Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2021)

Factors Influencing Menarcheal Age: Results From the Cohort of Tehran Lipid and Glucose Study
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2014)

Trend of Cardio-Metabolic Risk Factors in Polycystic Ovary Syndrome: A Population-Based Prospective Cohort Study
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2015)

The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS)
por: Rostami Dovom, Marzieh, et al.
Publicado: (2023)

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis
por: Wojciechowski, P., et al.
Publicado: (2012)

Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
por: Behboudi-Gandevani, Samira, et al.
Publicado: (2019)

Habitual dietary lactose and galactose intakes in association with age at menopause in non-galactosemic women
por: Rostami Dovom, Marzieh, et al.
Publicado: (2019)

Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol
por: Amiri, Mina, et al.
Publicado: (2017)

Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression
por: Bidhendi Yarandi, Razieh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jm5hecvnjfcsh07q8vbe85ttmc